A detailed history of Gagnon Advisors, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Gagnon Advisors, LLC holds 672,294 shares of LAB stock, worth $1.34 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
672,294
Previous 672,294 -0.0%
Holding current value
$1.34 Million
Previous $1.82 Million 34.71%
% of portfolio
0.98%
Previous 1.61%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.87 - $2.78 $1.26 Million - $1.87 Million
672,294 New
672,294 $1.82 Million

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $157M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Gagnon Advisors, LLC Portfolio

Follow Gagnon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gagnon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gagnon Advisors, LLC with notifications on news.